Search Within

Nora Katabi

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (12)
Groups
  1. Department of Pathology and Laboratory Medicine (36)
  2. Epidemiology and Biostatistics (36)
  3. Biostatistics Service (31)
  4. Department of Medicine (28)
  5. Surgery (26)
  6. Solid Tumor Oncology Division (25)

More Groups

People
  1. Alan Ho (19)
  2. Eric Sherman (18)
  3. David Pfister (17)
  4. Ian Ganly (12)
  5. Luc Morris (12)
  6. Lara Dunn (10)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2021 (2)
  4. 2019 (4)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Annals of Oncology (4)
  3. American Journal of Surgical Pathology (3)
  4. Annals of Surgical Oncology (3)
  5. Clinical Cancer Research (3)
  6. International Journal of Radiation Oncology, Biology, Physics (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Springer (6)
  3. Oxford University Press (5)
  4. Lippincott Williams & Wilkins (4)
  5. American Association for Cancer Research (3)
  6. Elsevier Inc. (3)

More Publishers

Results (36)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • What hides behind the MASC: Clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
    Journal Article

    Drilon, A.; Li, G.; Dogan, S.; Gounder, M.; Shen, R.; Arcila, M.; Wang, L.; Hyman, D. M.; Hechtman, J.; Wei, G.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Concurrent chemoradiotherapy with cisplatin versus cetuximab for squamous cell carcinoma of the head and neck
    Journal Article

    Riaz, N.; Sherman, E.; Koutcher, L.; Shapiro, L.; Katabi, N.; Zhang, Z.; Shi, W.; Fury, M.; Wong, R.; Wolden, S.; more...
    American Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Prognostic factors in myoepithelial carcinoma of salivary glands: A clinicopathologic study of 48 cases
    Journal Article

    Kong, M.; Drill, E. N.; Morris, L.; West, L.; Klimstra, D.; Gonen, M.; Ghossein, R.; Katabi, N.
    American Journal of Surgical Pathology (2015)

    Fulltext@MSK | Save
  • Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors
    Journal Article

    Hyman, D. M.; Snyder, A. E.; Carvajal, R. D.; Gerecitano, J. F.; Voss, M. H.; Ho, A. L.; Konner, J.; Winkelmann, J. L.; Stasi, M. A.; Monson, K. R.; more...
    Cancer Chemotherapy and Pharmacology (2015)

    Fulltext@MSK | Save
  • Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S.; Smith-Marrone, S.; Mueller, B.; Ng, K. K.; Dutta, P. R.; Gelblum, D. Y.; Lee, J. L.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S. L.; Smith-Marrone, S.; Ng, K. K.; Mueller, B.; Gelblum, D. Y.; Dutta, P. R.; Lee, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer
    Journal Article

    Fury, M. G.; Lee, N. Y.; Sherman, E.; Ho, A. L.; Rao, S.; Heguy, A.; Shen, R.; Korte, S.; Lisa, D.; Ganly, I.; more...
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • The mutational landscape of adenoid cystic carcinoma
    Journal Article

    Ho, A. S.; Kannan, K.; Roy, D. M.; Morris, L. G. T.; Ganly, I.; Katabi, N.; Ramaswami, D.; Walsh, L. A.; Eng, S.; Huse, J. T.; more...
    Nature Genetics (2013)

    Fulltext@MSK | Save
  • A phase I study of everolimus (E) plus weekly cisplatin (CDDP) plus intensity-modulated radiation therapy (IMRT) in head and neck (HN) cancer
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Ho, A. L.; Rao, S. S.; Shen, R.; Korte, S. H.; Lisa, D. M.; Ganly, I.; Katabi, N.; Patel, S. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Significance of CEACAM6 expression in biliary tract carcinoma
    Meeting Abstract

    Rocha, F. G.; Torres, J.; Chou, J. F.; Katabi, N.; Gonen, M.; DeMatteo, R. P.; Fong, Y. M.; Allen, P. J.; D'Angelica, M. I.; Klimstra, D. S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save